Page 3 of 5 · 111 questions tagged cardiovascular.
The particulars: SURMOUNT-5 · ecnoglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
What I have: SURMOUNT-5 · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
I have three data points across nine months, which I hope is enough to see a trend. This should be a straightforward calculation and I keep getting two different…
The specifics, since they change the answer: PIONEER-1 · ecnoglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret…
Concretely: STEP 4 · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which…
What I am working with: STEP 5 · cagrilintide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
For reference: SURMOUNT-1 · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Conditions: SUSTAIN-6 · liraglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
The particulars: STEP 4 · ecnoglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
The particulars: SUSTAIN-6 · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The case in front of me: STEP 1 · liraglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
I have the full paper rather than the abstract, and the supplementary appendix. I am at the decision point and I would rather think it through than improvise. I would…
The case in front of me: STEP 5 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
SOUL tested oral semaglutide 14 mg daily in people with type 2 diabetes and either atherosclerotic cardiovascular disease or chronic kidney disease, and reported a…
I am reading the trial table rather than the press release, which is why the numbers differ. I would like the arithmetic checked rather than the conclusion asserted.…
What I have: PIONEER-1 · dulaglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: STEP 2 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
Stated plainly: TRIUMPH-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Details up front: SUSTAIN-6 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
I have three data points across nine months, which I hope is enough to see a trend. I can do the algebra. I am not confident about the conversion factors. If there is…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. Please show the division. I want to check my own against yours. I…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I have worked this out and I would like someone to find…
What I am working with: FLOW · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…